9FWT
Ensemble model of ligand-free SARS-CoV-2 NSP10-NSP14 (ExoN) and in complex with partially bound VT00259
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | MAX IV BEAMLINE BioMAX |
| Synchrotron site | MAX IV |
| Beamline | BioMAX |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2022-07-09 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.97625 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 43.963, 99.926, 51.223 |
| Unit cell angles | 90.00, 114.70, 90.00 |
Refinement procedure
| Resolution | 46.530 - 1.639 |
| R-factor | 0.185 |
| Rwork | 0.183 |
| R-free | 0.21410 |
| Structure solution method | FOURIER SYNTHESIS |
| RMSD bond length | 0.010 |
| RMSD bond angle | 1.030 |
| Data reduction software | XDS (Jan 10, 2022) |
| Data scaling software | Aimless (0.7.7) |
| Phasing software | DIMPLE |
| Refinement software | BUSTER (2.10.4) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 46.535 | 46.535 | 1.667 |
| High resolution limit [Å] | 1.639 | 4.447 | 1.639 |
| Rmerge | 0.079 | 0.058 | 0.902 |
| Rmeas | 0.085 | 0.063 | 0.975 |
| Rpim | 0.032 | 0.024 | 0.367 |
| Total number of observations | 342597 | 17448 | 17027 |
| Number of reflections | 49263 | 2515 | 2468 |
| <I/σ(I)> | 14.02 | 33.47 | 2.21 |
| Completeness [%] | 100.0 | 99.9 | 100 |
| Redundancy | 6.95 | 6.94 | 6.9 |
| CC(1/2) | 0.998 | 0.996 | 0.769 |
| Anomalous redundancy | 3.5 | 3.6 | 3.5 |
| CC(ano) | 0.111 | 0.111 | -0.021 |
| |DANO|/σ(DANO) | 0.8 | 1.2 | 0.7 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 293 | Morpheus buffer 2 (pH: 7.5): 0.10M - Morpheus Ethylene glycols: 32.00%w/v Morpheus Amino acids: 0.11M |






